Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'tak 779'

Search results for: 'tak 779'

Items 1-10 of 51

Page
per page
  1. A 779
    B6056 A 779
     2 Citation
    Summary: angiotensin-(1-7)/ Mas receptor antagonist
      ≥29.1 mg/mL
  2. TAK 21d
    B4931 TAK 21d
    Summary: Potent FAAH inhibitor
  3. Mubritinib (TAK 165)
    B1543 Mubritinib (TAK 165)
    Target: ErbB
    Summary: Potent inhibitor of HER2/ErbB2
      insoluble in H2O; ≥76.9 mg/mL
  4. TAK-779
    BA1898 TAK-779
    Summary: TAK-779 is a potent, selective, non-peptide and antagonist.
  5. TAK-875
    A8339 TAK-875
    Target: GPR40
    Summary: GPR40 agonist
      ≥26.25 mg/mL
  6. TAK-593
    B3268 TAK-593
    Summary: dual VEGFR/PDGFR inhibitor
      Soluble in DMSO
  7. TAK-901
    A4124 TAK-901
    Target: Aurora Kinases|FLT3|Src|JAK|LRRK2|Hck|FGR|YES|Fyn|ARG
    Summary: Novel Aurora A/B inhibitor
      ≥25.25 mg/mL
  8. TAK-700 (Orteronel)
    A4326 TAK-700 (Orteronel)
     2 Citation
    Target: human lyase
    Summary: Human 17,20-lyase inhibitor
      insoluble in H2O; ≥11.2 mg/mL
  9. TAK-242
    A3850 TAK-242
     37 Citation
    Target: Toll-like receptors (TLRs)|NO Donors / Precursors|IL Receptors
    Summary: TLR4 inhibitor
  10. TAK-632
    A8226 TAK-632
    Target: Raf
    Summary: Pan-RAF inhibitor,potent and selective
      ≥27.75 mg/mL

Items 1-10 of 51

Page
per page